Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Hyperuricemia as a Risk Factor for Cardiovascular Diseases

Journal of Biomedicine and Translational Research · Vol. 6 No. 3 (2020) · hlm. 101–109

DOI
10.14710/jbtr.v6i3.9383
ISSN
2503-2178
Terbit
2020-12-31
Penerbit
Faculty of Medicine, Universitas Diponegoro
Bahasa
eng

Abstrak

Serum uric acid level above 7 mg/dl is defined as hyperuricemia, which gives rise to the monosodium urate (MSU), causing gout and urolithiasis. Hyperuricemia is an independent risk factor as well as a marker for hypertension, heart failure, atherosclerosis, atrial fibrillation, and chronic kidney disease. MSU crystals, soluble uric acid (UA), or oxidative stress derived from xanthine oxidoreductase (XOR) might be plausible explanations for the association of cardio-renovascular diseases with hyperuricemia. In macrophages, MSU activates the Nod-like receptor family, pyrin domain containing 3(NLRP3) inflammasome, and proteolytic processing mediated by caspase-1 with enhanced interleukin (IL)-1β and IL-18 secretion. Soluble UA accumulates intracellularly through UA transporters (UAT) in vascular and atrial myocytes, causing endothelial dysfunction ad atrial electrical remodeling. XOR generates reactive oxygen species (ROS) that lead to cardiovascular diseases. Since it remains unclear whether asymptomatic hyperuricemia could be a risk factor for cardiovascular and kidney diseases, European and American guidelines do not recommend pharmacological treatment for asymptomatic patients with cardio-renovascular diseases. The Japanese guideline, on the contrary, recommends pharmacological treatment for hyperuricemia with CKD to protect renal function, and it attaches importance of the cardio-renal interaction for the treatment of asymptomatic hyperuricemia patients with hypertension and heart failure.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 133 tautan kepenulisan bersama · 40 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Diponegoro University
  • Dr. Kariadi Hospital
  • Tottori University
  • University of Brawijaya
  • Sultan Agung Islamic University
  • Toranomon Hospital
  • State University of Semarang
  • Organisasi lain
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Etika Ratna NoerDiponegoro University2
Faizah FulyaniDiponegoro University2
Pipin ArdhiantoDiponegoro University2
Yan HerryDiponegoro University2
Sultana MH FaradzDiponegoro University2
Hery Djagat PurnomoDiponegoro University2
Rayvita AN MeagratiaDiponegoro University2
Ferdy Kurniawan CayamiDiponegoro University2
Wiwik LestariDiponegoro University2
Herera RahajengDiponegoro University1
Awal PrasetyoDiponegoro University1
Neni SusilaningsihDiponegoro University1
Udadi SadhanaDiponegoro University1
Hairul AsriDiponegoro University1
Anna Fuji RahimahUniversity of Brawijaya1
Mohammad Saifur RohmanUniversity of Brawijaya1
Qonita Nur QolbyState University of Semarang1
Muflihatul MunirohDiponegoro University1
Julian DewantiningrumDiponegoro University1
Besari Adi PramonoDiponegoro University1
Eka Djatnika NugrahaNational Research and Innovation Agency1
Adriyan PramonoDiponegoro University1
Kezia Yunandra KurniawanDiponegoro University1
Monica Hermina Sharon Otline YockuDiponegoro University1
Rachmania Anggita SavitriDiponegoro University1
Arynal HaqDiponegoro University1
Rebriarina HapsariDiponegoro University1
Muhammad Thifan SatyagrahaDiponegoro University1
Meita HendrianingtyasDiponegoro University1
Desy Ayu PuspitasariDr. Kariadi Hospital1
Ilham UddinDr. Kariadi Hospital1
Anindia WardhaniDr. Kariadi Hospital1
Misbah Hari CahyadiDr. Kariadi Hospital1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://ejournal2.undip.ac.id/index.php/jbtr/oai, pertama di-harvest 9 Nov 2026, terakhir terlihat 9 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Hyperuricemia as a Risk Factor for Cardiovascular Diseases</dc:title>
	<dc:creator>Hisatome, Ichiro</dc:creator>
	<dc:creator>Li, Peili</dc:creator>
	<dc:creator>Taufiq, Fikri</dc:creator>
	<dc:creator>Maharani, Nani</dc:creator>
	<dc:creator>Kuwabara, Masanari</dc:creator>
	<dc:creator>Ninomiya, Haruaki</dc:creator>
	<dc:creator>Bahrudin, Udin</dc:creator>
	<dc:subject xml:lang="en-US">hyperuricemia; cardiovascular disease; uric acid transporter; xanthine oxidase; inflammasome; guideline</dc:subject>
	<dc:description xml:lang="en-US">Serum uric acid level above 7 mg/dl is defined as hyperuricemia, which gives rise to the monosodium urate (MSU), causing gout and urolithiasis. Hyperuricemia is an independent risk factor as well as a marker for hypertension, heart failure, atherosclerosis, atrial fibrillation, and chronic kidney disease. MSU crystals, soluble uric acid (UA), or oxidative stress derived from xanthine oxidoreductase (XOR) might be plausible explanations for the association of cardio-renovascular diseases with hyperuricemia. In macrophages, MSU activates the Nod-like receptor family, pyrin domain containing 3(NLRP3) inflammasome, and proteolytic processing mediated by caspase-1 with enhanced interleukin (IL)-1β and IL-18 secretion. Soluble UA accumulates intracellularly through UA transporters (UAT) in vascular and atrial myocytes, causing endothelial dysfunction ad atrial electrical remodeling. XOR generates reactive oxygen species (ROS) that lead to cardiovascular diseases. Since it remains unclear whether asymptomatic hyperuricemia could be a risk factor for cardiovascular and kidney diseases, European and American guidelines do not recommend pharmacological treatment for asymptomatic patients with cardio-renovascular diseases. The Japanese guideline, on the contrary, recommends pharmacological treatment for hyperuricemia with CKD to protect renal function, and it attaches importance of the cardio-renal interaction for the treatment of asymptomatic hyperuricemia patients with hypertension and heart failure.</dc:description>
	<dc:publisher xml:lang="en-US">Faculty of Medicine, Universitas Diponegoro</dc:publisher>
	<dc:date>2020-12-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US"></dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://ejournal2.undip.ac.id/index.php/jbtr/article/view/9383</dc:identifier>
	<dc:identifier>10.14710/jbtr.v6i3.9383</dc:identifier>
	<dc:source xml:lang="en-US">Journal of Biomedicine and Translational Research; Vol 6, No 3 (2020): December2020; 101-109</dc:source>
	<dc:source>2503-2178</dc:source>
	<dc:source>10.14710/jbtr.v6i3</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://ejournal2.undip.ac.id/index.php/jbtr/article/view/9383/5108</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2020 Journal of Biomedicine and Translational Research</dc:rights>
</oai_dc:dc>